Hepatic arterial infusion chemotherapy with or without lenvatinib for unresectable cholangiocarcinoma: a single-center retrospective study.
Yajing WangZhanqi WeiZheng ZhangJingyi XuYaqin WangQian ChenYuewei ZhangPublished in: Hepatic oncology (2023)
FOLFOX-HAIC plus lenvatinib has the potential to be a treatment option for unresectable cholangiocarcinoma.